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Introduction: Severe acute pancreatitis is still a potentially life threatening disease with high mortality. The aim of
this study was to evaluate the therapeutic effect of thoracic epidural anaesthesia (TEA) on survival, microcirculation,
tissue oxygenation and histopathologic damage in an experimental animal model of severe acute pancreatitis in a
prospective animal study.
Methods: In this study, 34 pigs were randomly assigned into 2 treatment groups. After severe acute pancreatitis
was induced by intraductal injection of glycodesoxycholic acid in Group 1 (n = 17) bupivacaine (0.5%; bolus
injection 2 ml, continuous infusion 4 ml/h) was applied via TEA. In Group 2 (n = 17) no TEA was applied. During a
period of 6 hours after induction, tissue oxygen tension (tpO2) in the pancreas and pancreatic microcirculation was
assessed. Thereafter animals were observed for 7 days followed by sacrification and histopathologic examination.
Results: Survival rate after 7 days was 82% in Group 1 (TEA) versus 29% in Group 2: (Control) (P <0.05). Group 1
(TEA) also showed a significantly superior microcirculation (1,608 ± 374 AU versus 1,121 ± 510 AU; P <0.05) and
tissue oxygenation (215 ± 64 mmHg versus 138 ± 90 mmHG; P <0.05) as compared to Group 2 (Control).
Consecutively, tissue damage in Group 1 was reduced in the histopathologic scoring (5.5 (3 to 8) versus 8
(5.5 to 10); P <0.05).
Conclusions: TEA led to improved survival, enhanced microcirculatory perfusion and tissue oxygenation and
resulted in less histopathologic tissue-damage in an experimental animal model of severe acute pancreatitis.Introduction
Severe acute pancreatitis (SAP) is a life threatening dis-
ease with a high mortality despite improved treatment
strategies. The incidence of SAP has increased during
the last decades [1,2]. Progression from the mild edema-
tous to the hemorrhagic necrotizing form determines
outcome [3-8]. Up to now, no causal treatment of
pancreatitis is known. Although the pathophysiologic
cascade of its development and progress is poorly under-
stood, microcirculatory disturbances are considered to
be a key factor [9,10].* Correspondence: c.trepte@uke.de
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reproduction in any medium, provided the orThe rationale of this trial is based on the generally
accepted finding that an improvement of pancreatic
microcirculation prevents the progression from mild
edematous to severe necrotizing pancreatitis [3-7,11].
Different therapeutic interventions for improving pancre-
atic microcirculation have been evaluated in the last years
[9,12-16]. Therapeutic efforts aim at saving injured tissue
from infarction and necrosis by improving microcircu-
latory perfusion and oxygen supply. The main idea in our
approach is sympathetic block by thoracic epidural
anesthesia (TEA) with consecutive redistribution of blood
flood toward the splanchnic vessels [17]. This effect could
be demonstrated in various trials [18-21]. In perioperative
and experimentally induced hemorrhage positive effects
due to epidural anesthesia on gastrointestinal microcir-
culation could be demonstrated [22,23]. TEA is further
reported to improve renal and gastrointestinal perfusiontral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vascular blood flow in the liver or ileal mucosa in other
models of systemic inflammation [24,26]. Some first
attempts also showed promising results for the use of
TEA in pancreatitis demonstrating reduced liver injury,
improved ileal mucosal capillary perfusion and survival as
well as pancreatic microcirculation in the rat [26-28].
Another aspect is,that microcirculation is also dependent
on macrocirculatory conditions and an adequate macro-
circulation is an indispensible precondition. For evaluation
of macrocirculatory conditions the use of advanced hemo-
dynamic monitoring has substantially increased in recent
years in intensive care and perioperative settings [29]. In
part, results of this study have already been reported
demonstrating the impact of two different treatment strat-
egies for early goal-directed fluid therapy [30]. However,
to date no data and final validation exist evaluating the
therapeutic effect of TEA in SAP during controlled
hemodynamic conditions. We hypothesized that improve-
ment of microcirculation due to redistribution of blood
flow in the inflamed tissue by TEA would result in
improved pancreatic microcirculatory conditions and
outcome in SAP.
Therefore, the aim of this study was to evaluate the
therapeutic effects of TEA in an experimental model of
SAP. The primary outcome variable was survival after
seven days. Secondary outcome variables were pancre-
atic microcirculation and tissue oxygenation during the
first six hours after induction as well as the extent of
histopathologic tissue-damage.
Materials and methods
The study was approved by the Governmental Commission
on the Care and Use of Animals of the City of Hamburg.
The animals received care in compliance with the ‘Guide
for the Care and Use of Laboratory Animals’ (NIH publi-
cation No. 86–23, revised 1996) and experiments were
carried out according to the ARRIVE guidelines [31].
Study design
The study was designed as a randomized trial in 34
German domestic pigs (German Hybrid). Animals were
randomized to two different treatment groups: Group 1
(TEA, n = 17) received TEA after induction of SAP. In
Group 2, acute pancreatitis was induced, however no
TEA was performed (Control; n = 17).
Anesthesia and surgical preparation
After fasting overnight, ketamine (10 mg/kg), azaperone
(4 mg/kg), midazolam (15 mg) and atropine (0.0015 mg/kg)
were administered for premedication. After preoxygenation,
induction of anesthesia and orotracheal intubation were
performed. Continuous infusion of fentanyl (0.05 mg/kg/
hour) and sevoflurane (Fet 2.0) were used for balancedanesthesia. The animals were mechanically ventilated
using tidal volumes of 10 ml/kg. Inspiratory oxygen
fraction (FiO2) was set at 0.35 and respiratory rate was ad-
justed to maintain end expiratory pCO2 at 35 to 40 mmHg
(Zeus, Draeger Medical Systems, Lübeck, Germany).
Moreover, a gastric tube was brought into position. For
monitoring of heart rate and oxygen saturation a 5-lead
electrocardiogram and pulse oximetry were used. Body
temperature was kept constant using forced-air warming
blankets.
Prior to the beginning of further surgical preparation,
animals randomized to Group 1 (TEA) were positioned
on the right side and a thoracic epidural catheter was
introduced between Th 7 and Th 8 under sterile con-
ditions and radiographic control. The catheter was
advanced 2 cm into the epidural space and correct posi-
tioning of the catheter was verified and documented by
an epidurogram as gold standard (Figure 1). For these
purposes 5 ml of contrast agent were injected in the
epidural space during fluoroscopy to exclude an intra-
vascular position of the catheter. Thereby, it was verified
that a minimal spread over 6 to 8 segments was present
and no misplacement of the epidural catheter had
occurred.
All animals were placed in the supine position and after
thorough disinfection and sterile coverage, the femoral ar-
tery was canulated using a 5 F thermistor tipped arterial
catheter (PICCO, PV 2015 L20, Pulsion, Feldkirchen,
Germany). Two central venous catheters were surgically
introduced into the internal and external jugular vein, one
for volume administration, the other to enable injection of
cold indicator for transcardiopulmonary thermodilution.
Hemodynamic data were recorded using a PiCCOplus
monitoring system (version 6.0, Pulsion Medical Systems,
Munich, Germany).
Thereafter, a transverse upper laparotomy was perfor-
med. A urinary catheter was placed directly into the
bladder for urinary drainage and intraoperative account-
ing of urine. Pancreas and duodenum were mobilized
and fixed at the laparotomy incision for intraoperative
measurements, whereupon meticulous attention was
paid to strainless positioning. After dissection and can-
nulation of the main pancreatic duct (Vasofix 0,8 mm, B.
Braun, Melsungen, Germany) between the pancreas and
duodenal wall, a flexible polarographic measuring probe
(CCP1, Licox, Kiel, Germany) was placed in the pan-
creatic head for continuous measurement of the tissue
oxygen tension (tpO2) [32,33]. A Laser-Doppler imager
(Laser-Doppler Imager LDI2, Moor, Millway, UK), was
installed to assess microcirculation in the pancreatic
head. The laser is scattered by the tissue and moving
blood cells in the capillaries, arterioles and venules. The
moving blood cells cause frequency shifts that are proc-
essed to produce a color coded map of the scanned area.
Figure 1 Epidurogram after placement of the epidural catheter.
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pancreas and the region of interest (pancreas) was marked
in a color coded map of the corresponding image. The
mean microcirculation in the region of interest was
calculated automatically [9].
Hemodynamic management
In both groups hemodynamic management was carried
out according to a defined treatment algorithm [30].
Ringer’s solution and hydroxyethylstarch 6% 130/0.4
were administered at a fixed ratio of 2:1. The treatment
algorithm for guidance of fluid therapy is presented in
Figure 2. Hemodynamic data were assessed continuously
during the entire procedure as well as with each point of
measurement.
Therapeutic intervention
Animals in Group 1 (TEA, n = 17) received TEA after
induction of acute pancreatitis. Initially, a bolus of 2 mlFigure 2 Algorithm for guidance of fluid therapy. Stroke volume variatbupivacaine 0.5% was given via the epidural catheter,
followed by a continuous application at a fixed rate of
4 ml/hour using an automated infusion pump (Pega® Plus,
Venner Medical, Kiel Germany). We aimed for blocking
three to four segments above and below the site of
insertion.
In group 2 (control; n = 17), acute pancreatitis was
induced while no TEA was performed.
Measurement and experimental protocol
After an initial equilibration, baseline measurements
(M0) were performed. Measurements included blood gas
analysis, measurement of tpO2 and microcirculation in
the pancreatic head as well as thermodilution measure-
ments for assessment of hemodynamic conditions. After
completion of baseline measurements, in both groups
SAP was induced by intraductal infusion of 0.8 ml/kg gly-
codesoxycholic acid (10 mmol/L, pH 8, Sigma, Steinheim,
Germany) during a period of 15 minutes as previouslyion (SVV), Cardiac Index (CI), mean arterial pressure (MAP).
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fm (MFC), B Braun, Melsungen, Germany) to ensure a
standardized infusion pressure and avoid pancreatic
pressure necrosis [4,9,30,34]. Thereafter, the cannula was
removed and the pancreatic duct was ligated. Fifteen
minutes (M1) and 75 (M2) minutes after completion of
the intraductal infusion, measurements were repeated.
After M2 in animals randomized to Group 1 (TEA) a
bolus of bupivacaine was applied via the epidural catheter,
immediately followed by a continuous application at a
fixed rate as described. After the beginning of the
therapeutic intervention, measurements were repeated
every 60 minutes (M3 to M8). After completion of the
intraoperative measurements (M8), all catheters were
removed except for the TEA catheter in Group 1 (TEA) as
well as a central line, tunneled to the dorsal neck, for
application of analgesic medication and blood gas sam-
pling in the postoperative course. The abdominal cavity
and incision of the neck were closed and anesthesia was
ceased. The animals were extubated and transferred to
heated boxes in the animal facility. In animals randomized
to Group 1 (TEA) the infusion pump for application of
bupivacain via the epidural catheter during the postopera-
tive observation interval was attached to the back using a
special dressing.
Survival and postoperative observation
Animals were closely monitored for seven days. Analgesics
were given every six hours (piritamide 15 mg). Once a day
blood samples for evaluation of pancreatic amylase, total
bilirubin (TBIL), liver enzymes (aspartate-transaminase
(AST), alanine-transaminase (ALT)), leucocyte count,
lactate, creatinine, prothrombin time (PT) and partial
thromboplastin time (pTT) were taken via the central
venous catheter and laboratory analysis was carried out.
Hemoglobin, leucocytes and thrombocytes were counted
with a fully automatic blood count analysis unit. TBIL was
measured by spectral absorption while the measurement
of ALT and AST was based on their enzyme activity. The
concentration of amylase was measured by an amylase
activity enzyme kit (Abcam, Cambridge, UK). Isotope di-
lution mass spectrometry was applied to analyze serum
creatinine. PT and pTT were measured in a fully auto-
mated system as well. Moreover, porcine well-being was
assessed in all animals [35].
Animals surviving the observation period were re-
anesthetized on the seventh postoperative day, and
sacrificed by fast injection of potassium chloride during
deep anesthesia. The correct positioning of the thoracic
epidural catheter was reconfirmed by another epiduro-
gram. Postmortem examination was carried out and the
pancreas was removed for histopathologic examination. In
animals that died during the postoperative observation
period postmortem examination, removal of the pancreasand the epidurogram were conducted immediately after
diagnosis of death. Specimens of the pancreas were stored
in 3.5% buffered formalin and routinely processed. They
were embedded in paraffin and 5 μm slices were stained
with hematoxylin and eosin. The slices were examined by
an experienced pathologist blinded to the treatment (AH)
using an established scoring system [9,30]. The median
score of the histopathologic examination is based on the
analysis of 10 high power fields (HPF) in four different
slices.
Power calculation and statistical analysis
The primary endpoint of the trial was survival. Secondary
endpoints were pancreatic microcirculation, tissue oxy-
genation and histopathologic tissue damage. A detectable
difference of 25% versus 75% in survival was used to
calculate group size. The calculated group size (using 5%
alpha error and 80% power) was n = 17. SPSS® for
Windows® (Version 13.0) (SPSS Inc., Chicago, IL, USA)
was used for statistical analysis. Survival curves were plot-
ted using the Kaplan-Meier method and data were analyzed
using the log-rank test. Assessment of normal distribution
was conducted using the Kolmogorov-Smirnov-Test.
Descriptive analysis of parametric parameters is expressed
as means and standard deviation. Ordinal data were
expressed as median and range. For analysis of the differ-
ence between the groups in repeated measurements the
variance analysis for repeated measurements (ANOVA)
followed by a time-by-treatment-interaction test was used.
Additionally, the area under the curve was calculated
during the intraoperative treatment interval (M2 to M8).
Differences between the treatment groups were analyzed
using a one way ANOVA. Significance statements refer to
P values of two-tailed tests that were less than 0.05.
Results
In both groups, 17 animals were studied. There were no
statistically significant differences between the different
treatment groups. Mean body weight of the animals in
Group 1 (TEA) was 32.0 ± 7.5 versus 32.0 ± 6.9 kg in
Group 2 (Control), while mean body length was 102 ±
5 cm and 102 ± 6 cm (P >0.05).
Survival and postoperative observation
Overall survival after seven days was 82.4% in Group 1
(TEA) versus 29.4% in Group 2 (Control) (P <0.001).
Survival data are presented in Figure 3.
During the postoperative course, evaluation of the
‘Porcine Well-being Score’ also demonstrated signifi-
cantly better results in Group 1 (TEA) (Table 1).
Tissue oxygenation and microcirculation of the pancreas
In both groups (groups 1 and 2), strong decreases of pan-
creatic microcirculation (Flux) and tpO2 were detected
Figure 3 Kaplan Meier curve for survival of animals in
the postoperative treatment interval (TEA Group versus
Control-Group).
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pancreatic microcirculation improved in Group 1 (TEA)
and a significant time-by-treatment interaction was de-
tected in the variance analysis for repeated measurements
(P <0.001). Comparing the areas under the curve during
the treatment interval a significantly enhanced pancreatic
microcirculation was found in Group 1 (TEA) (1,608.4 ±
374.4) versus Group 2 (Control) (1,121.0 ± 510.) (P = 0.003)
(Figure 4). Concerning the tissue oxygenation, a sig-
nificant time-by-treatment interaction was detected
in the variance analysis for repeated measurements
(P <0.001) and when comparing the areas under the
curve during the treatment interval a significantly bet-
ter tissue oxygenation was found in Group 1 (Group
1 (TEA) 215 ± 64 in comparison to Group 2 (Control)
138 ± 90; P = 0.007) (Figure 4). The detailed course is
presented in Table 2.
Histopathologic examination
Histopathologic tissue examination revealed a lower sever-
ity of acute pancreatitis in Group 1 (TEA) compared to
Group 2 (Control). Overall histopathologic pancreatitis
score was 5.5 (3 to 8) (Group 1 (TEA)) versus 8 (5.5 to 10)
(Group 2 (Control)) (P <0.001). Details on histopathologic
scoring for acinar necrosis, fatty tissue necrosis, inflamma-
tion and edema in the pancreatic head are presented in
Table 3.Table 1 Scoring results of the porcine wellbeing score
Porcine wellbeing score Day 1 Day 2 Day
TEA 34 ± 13 35 ± 17 34 ± 1
Control 28 ± 17 29 ± 20 27 ± 2
*Represents statistically significant difference (P <0.05). Data are presented as meanHemodynamics and fluid balance
Hemodynamic data on macrocirculatory conditions did
not present any significant differences during the entire
intraopaerative period. Neither norepinephrine nor epi-
nephrine was applied in either of the treatment groups.
Detailed data on hemodynamics and fluid balance are
presented in Table 2. The amount of fluids infused also
did not differ between the treatment groups.
Laboratory data
Neither arterial blood gas analysis during the treatment
interval (M2 to M8) nor analysis of pancreatic amylase,
liver enzymes, bilirubin, leucocyte count, lactate, and
creatinine, from the blood samples taken in the pos-
toperative observation period, presented any significant
differences between the two treatment groups (P >0.05);
(Table 4).
Discussion
This study analyzed the effects of TEA in SAP in an
experimental setting. We found that TEA improved
survival as well as pancreatic microcirculation and tissue
oxygenation resulting in reduced histopathologic tissue
damage. It is the first study assessing the effects of TEA
during controlled hemodynamic conditions comparable
to an intensive care setting. This is a necessary prerequis-
ite to reliable assessment of microcirculatory dysfunction
and tissue oxygenation.
The rationale for the use of TEA in acute pancreatitis
is that intestinal and hepatic perfusion is regulated by
sympathetic and parasympathetic nerves. In healthy
subjects the regulation of blood flow is optimized for
maintaining metabolic stability. During resting con-
ditions the sympathetic tone is low and blood flow is
mainly regulated by vagal tone activity. An increasing
sympathetic activity resulting in an intestinal vasocon-
striction and consequently reduced blood flow has been
shown in acute stress and pain [28]. This is also true for
systemic inflammation where the microcirculation is
affected [22,36,37]. The effects of TEA have been
analyzed in different experimental models. Adolphs and
co-workers were able to detect an improved microcircu-
lation after TEA during hemorrhage-induced impair-
ment of intestinal perfusion [38]. Additionally, there are
several studies in animals suffering from systemic
inflammation demonstrating the benefits of using TEA.
Models using cecal ligation to induce severe systemic3 Day 4 Day 5 Day 6 Day 7
7 35 ± 17 37 ± 18 37 ± 18 36 ± 18
1 25 ± 22 23 ± 23 17 ± 22* 14 ± 22*
± standard deviation. (Scoring Range: 0 to 50).
Figure 4 Microcirculation and tissue oxygenation (tpO2). a) Pancreatic microcirculation and b) tissue oxygenation in the pancreatic head.
(MP0 = before induction of the acute pancreatitis, MP1 and 2 after induction of the acute pancreatitis, MP3 to 8 during TEA. Mean and standard
deviation; Value in Flux (Arbitrary Unit (AU)).
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induced alterations of hepatic blood flow as well as
improved mucosal microcirculation in rats [24,26]. In a
model of systemic inflammation during endotoxemia in
an ovine model as well as in the rat, superior renal
perfusion as well as an attenuation of impairment of
gastrointestinal organ perfusion and improved micro-
vascular mucosa perfusion could be demonstrated
[22,24,25]. A study by Lauer et al. demonstrated that
TEA also improved pulmonary endothelial integrity in
hyperdynamic sepsis [39].
Data regarding TEA and pancreatitis are rare. Up to
now, only two feasibility studies using TEA in acute
pancreatitis in humans have been published. In the first
trial, it was shown that the use of TEA is safe and the
rate of complications is low, although no control group
was investigated. In the second trial, TEA was found to
be superior in terms of pain management [40,41]. Over-
all, no clinical data concerning the therapeutic effect of
TEA in SAP, especially on improvement of outcome and
survival, are available. Since there is enormous experi-
ence in the clinical use of TEA in humans for major
abdominal and thoracic surgery, as well as for acute and
chronic pain management, the implementation of TEA
in the early treatment of SAP appears possible if no
contraindications are present. Nonetheless, the idea of
also using TEA in systemic inflammation and sepsis is
still controversial [42]. Up to now, three experimental
trials analyzing the impact of TEA in acute pancreatitis
in rats have been published. In a setting similar to ours,
Demirag and co-workers for the first time demonstrated
an improved pancreatic microcirculation also using laser
Doppler flowmetry as well as reduced histopathologic
damage in a small series in the rat. However, no survival
data were available [27]. Freise et al. were the first toanalyze the impact of TEA on survival in an experimen-
tal model of SAP in the rat. Besides improved seven day
survival they found an increased capillary perfusion and
lower Inflammation, while no significant difference
regarding histopathologic damage was present [43]. An-
other study by Freise and coworkers analyzed the impact
of TEA on the liver in acute pancreatitis. Here, a reduc-
tion of the vasoconstriction of the sinusoids and reduced
apoptosis was found [28]. These data are completely in
accordance with our findings that applying TEA resulted
in improved microcirculation and oxygenation of the
pancreas and, finally, better survival as well as less histo-
pathologic damage in SAP. Moreover, in our study the
effects of TEA on survival could be evaluated in a model
in which TEA was applied continuously over a period of
seven days similar to a clinical setting, since animals
were equipped with an automated infusion pump. To
date, for practical reasons no direct assessment of
pancreatic microcirculation exists in awake animals.
Nonetheless, the effect of sympathetic block by TEA has
also been demonstrated for awake animals [44]. In the
animals included in this study no obvious signs of a
motor block were present. Unfortunately, there is no
reliable and validated method to assess analgesic effects
and a sensory block, such as a pain scoring system, avail-
able in pigs. Although for reasons of the experimental
setup no direct evaluation of the sympathicolytic effect
was carried out, the correct positioning of the epidural
catheter was verified at the end of the observation
period by performing another epidurogram. Therefore,
we can only postulate that the epidural catheter was in
the correct position and that due to the application of
bupivacaine a sympathetic block and a sensory effect
were present and that the detected effects of TEA on
pancreatic microcirculation and tissue oxygenation
Table 2 Data on microcirculation, tissue oxygenation, hemodynamics, blood gas analysis and fluid balance
Parameter Group M 0 M 1 M 2 M 3 M 4 M 5 M 6 M 7 M 8
Tissue oxygenation(tpO2 mmHg) 1 (TEA) 63.8 ± 14.1 40.2 ± 17.7 32.5 ± 11.4 36.3 ± 13.7 37.1 ± 12.2 36.8 ± 11.0 36.2 ± 10.5 35.2 ± 9.1 35.0 ± 9.1
2 (Control) 64.2 ± 14.1 45.2 ± 21.4 32.4 ± 16.2 25.7 ± 15.9* 22.8 ± 15.6* 22.2 ± 15.9* 20.4 ± 15.0* 20.5 ± 14.3* 20.4 ± 14.2*
Microcirculation(Flux AU) 1 (TEA) 391.9 ± 82.8 253.3 ± 81.2 236.1 ± 55.1 288.9 ± 73.4 300.4 ± 68.5 276.2 ± 65.7 254.1 ± 73.8 249.9 ± 66.0 241.5 ± 97.0
2 (Control) 408.5 ± 88.3 267.4 ± 103.4 233.2 ± 56.3 215.9 ± 104.9* 201.8 ± 108.1* 182.4.0 ± 90.0* 168.6 ± 89.0* 160.5 ± 80.7* 150.6 ± 85.7*
HR (min-1) 1 (TEA) 90.5 ± 24.9 91.9 ± 24.5 95.4 ± 21.5 94.4 ± 19.9 97.7 ± 16.8 100.7 ± 16.3 99.4 ± 14.6 99.3 ± 10.3 99.4 ± 13.2
2 (Control) 85.5 ± 13.8 85.4 ± 14.9 91.1 ± 16.6 95.5 ± 16.7 98.9 ± 15.0 101.0 ± 13.8 103.3 ± 14.7 102.6 ± 16.5 100.8 ± 11.3
MAP (mmHg) 1 (TEA) 72.5 ± 10.6 74.1 ± 11.5 76.8 ± 10.6 74.8 ± 8.7 74.9 ± 8.4 70.9 ± 7.2 67.2 ± 6.6 64.1 ± 5.3 62.2 ± 6.2
2 (Control) 74.7 ± 10.4 73.3 ± 8.3 73.5 ± 9.4 73.4 ± 7.7 73.1 ± 11.2 69.6 ± 5.8 66.5 ± 6.7 64.2 ± 6.2 61.9 ± 6.8
CI (L/min) 1 (TEA) 4.7 ± 1.3 4.9 ± 1.3 5.2 ± 1.1 5.1 ± 0.9 5.0 ± 0.9 5.2 ± 0.9 4.8 ± 0.7 4.6 ± 0.5 4.7 ± 0.8
2 (Control) 4.6 ± 0.8 4.6 ± 0.8 5.1 ± 1.1 5.1 ± 0.8 5.1 ± 0.9 5.1 ± 0.9 5.2 ± 1.0 5.2 ± 1.1 5.2 ± 0.9
SVV (%) 1 (TEA) 6.5 ± 2.7 6.2 ± 1.1 5.9 ± 1.0 5.9 ± 1.0 7.1 ± 1.9 7.1 ± 1.5 6.5 ± 1.5 7.1 ± 1.5 7.3 ± 1.5
2 (Control) 6.6 ± 1.6 6.8 ± 1.6 6.1 ± 1.3 6.1 ± 1.3* 6.9 ± 1.8* 6.6 ± 0.9* 6.2 ± 1.6* 6.8 ± 1.7* 7.2 ± 2.6*
CVP (mmHg) 1 (TEA) 6.7 ± 1.9 6.6 ± 1.7 7.0 ± 1.9 6.6 ± 2.3 6.5 ± 2.2 6.4 ± 1.7 6.6 ± 1.8 6.7 ± 1.6 6.6 ± 1.9
2 (Control) 7.2 ± 2.4 6.6 ± 1.9 7.1 ± 2.0 7.0 ± 1.7 7.1 ± 2.0 7.2 ± 2.2 7.8 ± 2.3 7.5 ± 2.6* 8.1 ± 2.9*
paO2 (mmHg) 1 (TEA) 161.1 ± 67.7 147.8 ± 24.9 139.1 ± 14.7 137.1 ± 12.7 134.7 ± 16.5 131.1 ± 17.6 130.2 ± 18.0 126.8 ± 17.2 125.3 ± 17.3
2 (Control) 159.2 ± 21.2 145.4 ± 16.8 141.1 ± 14.9 138.6 ± 16.7 128.8 ± 12.7 124.8 ± 18.2 122.4 ± 17.1 118.4 ± 16.6 115.9 ± 18.7
ScvO2 (%) 1 (TEA) 72.8 ± 8.4 75.2 ± 8.3 73.9 ± 10.8 74.4 ± 11.7 73.6 ± 13.2 71.6 ± 12.6 71.3 ± 9.6 69.1 ± 9.3 65.6 ± 12.9
2 (Control) 81.6 ± 9.9 77.5 ± 9.6 79.4 ± 9.8 77.3 ± 9.4 70.8 ± 12.3 73.6 ± 12.2 73.4 ± 11.0 74.8 ± 11.5 72.0 ± 12.5
Lactate(mmol/L) 1 (TEA) 0.9 ± 0.3 0.8 ± 0.2 0.8 ± 0.2 0.9 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 0.7 ± 0.2 0.7 ± 0.2 0.7 ± 0.2
2 (Control) 0.9 ± 0.3 0.9 ± 0.4 0.9 ± 0.4 0.9 ± 0.4 0.8 ± 0.3 0.7 ± 0.2 0.6 ± 0.2 0.6 ± 0.2 0.6 ± 0.2
Colloids (ml) 1 (TEA) 59 ± 141 121 ± 193 397 ± 235 518 ± 203 676 ± 290 879 ± 367 1.088 ± 434 1.294 ± 460 1.594 ± 560
2 (Control) 0 ± 0 50 ± 132 174 ± 209 388 ± 172 538 ± 156 768 ± 225 1.032 ± 171 1.382 ± 269 1.694 ± 420
Cristalloids (ml)s 1 (TEA) 757 ± 210 1047 ± 325 1.268 ± 403 1.518 ± 460 1.844 ± 548 2.347 ± 637 2.756 ± 748 3.232 ± 968 3.606 ± 1.103
2 (Control) 621 ± 211 932 ± 292 1.271 ± 335 1.415 ± 363 1.829 ± 357 2.276 ± 370 2.788 ± 501 3.300 ± 663 0.3800 ± 794
Urine (ml) 1 (TEA) 297 ± 271 406 ± 370 579 ± 491 682 ± 552 1.012 ± 702 1.294 ± 833 1.571 ± 1.015 1.868 ± 1.166 2.188 ± 1.343
2 (Control) 206 ± 228 335 ± 337 582 ± 559 762 ± 644 1.065 ± 748 1.424 ± 858 1.876 ± 1.013 2.376 ± 1.136 2.844 ± 1.305
Values for tissue oxygenation (tpo2 (mmHg)), microcirculatory flow (Flux (AU)), Heart rate (HR (min-1)), mean arterial pressure (MAP (mmHg)), cardiac index (CI (L/min)), systemic vascular resistance (SVRi (dynes*sec/cm5/m2)),
stroke volume variation (SVV (%)), central venous pressure (CVP (mmHg)), arterial partial oxygen pressure (paO2 (mmHg)), central venous oxygen saturation (ScvO2 (%)), lactate measured in arterial blood gas analysis (mmol/L),
cumulative crystalloid infusion (ml), cumulative colloid infusion (ml) and urine output (ml). Data are presented as mean ± standard deviation. *represents statistically significant differenence between treatment groups (P <0.05)













Table 3 Histopathologic scoring for severity of acute porcine pancreatitis
Histopathologic severity score of acute pancreatis
Group Acinar necrosis* Fatty tissue necrosis* Inflammation Edema* Overall*
Group 1
(TEA)
2 (0–3) 1 (0–2) 2 (0–2) 1 (0–2) 5.5 (3–8)
Group 2
(CONTROL)
3 (0–3) 2 (1–3) 2 (1–3) 1.5 (0.5-3) 8 (5.5-10)
Acinar necrosis Fatty tissue necrosis
(in relation to plane)
Inflammation (plasma cells,
lymphocytes and granulocytes
outside parechymal and fatty tissue)
Edema
0 nil 0 nil 0 nil 0 nil
1 <10 single
necrosis/lobule
1 <1/3 of plane 1 loose infiltrates (≤30 cells/HPF) 1 intralobular edema
2 ≥10 single
necrosis/lobule
2 ≥1/3 to <2/3
of plane
2 moderate infiltrates (30–99 cells/HPF) 2 interacinar edema,
≥2 lobules
* P < 0.05 3 ≥1/3 of plane 3 ≥2/3 of plane 3 dense infiltrates (≥100 cells/HPF) 3 intercellular edema, ≥2 lobules
*P <0.05 representing statistically significant difference. Data are presented as median (range); Pancreatitis Score: 0 (no pancreatitis) to 12 (severe pancreatitis);
histopathologic pancreatitis score (0 to 12 points) including acinar necrosis (0 to 3) fatty tissue necrosis (0 to 3), inflammation (0 to 3) and Edema (0 to 3).
HPF: High power field; TEA, thoracic epidural anesthesia.
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http://ccforum.com/content/17/6/R281during the intraoperative treatment period are present
during the entire protocol, thereby contributing to the
superior survival of the TEA group. Our findings are,
therefore, in accordance with the aforementioned theor-
etical considerations and are in line with the positive
effects observed in other models of systemic inflam-
mation using endotoxemia or bowel perforation. What
has to be considered is that, overall, not only pancreatic
microcirculation but also other aspects, such as impro-
ved intestinal mucosal perfusion with less gut barrier
dysfunction and improved liver perfusion, potentially
might have contributed to improved survival in our
setting, especially since the liver also is involved in a
multitude of physiologic processes and decisively con-
tributes to the host’s immune reaction in sepsis and
inflammation [28].
Some other aspects need to be taken into consider-
ation. With a view to the evaluation of effectiveness of
the treatment of SAP, it is important that a model is
used that closely mimics the clinical situation with a
high mortality in SAP where the severity of the pancrea-
titis ensures that some animals survive but also that
some animals die without treatment. In our setting a
model of intraductal injection of bile acid in the main
pancreatic duct followed by closure was used. The
model closely represents the clinical situation of acute
biliary pancreatitis caused by obstruction of the papilla
by bile stones and has been established in previous trials
[9,45-47]. Another advantage of the model is that it
allows a very high standardization, using standardized
dosages and infusion pressures unlike other models that
induce SAP by ischemia, hypotension or ingestion of
alcohol [48,49].
Another consideration is that in our study we cannot ex-
plicitly demonstrate the sympathetic block. Measurementsof the arterial plasma levels of epinephrine and norepin-
ephrine were not carried out and also thermal imaging
was not possible because of the experimental setup. When
looking at hemodynamics we also could not find a signifi-
cant impact due to the onset of TEA. The level chosen at
Th 7/8 for TEA will not result in relevant vasodilation of
capacitance vessels; neither should there be a relevant
effect on the nervi accelerantes. Therefore, according to
our understanding, it is not surprising that the onset of
TEA did not present with significant changes and result in
significant differences of hemodynamic parameters.
In addition to the data presented, we analyzed the
effects of TEA in a small series of healthy animals as
well, where no experimental induction of pancreatitis
was carried out. In one group only surgical preparation
was carried out, while in the other group surgical prep-
aration and TEA were performed. Most importantly, it
was shown that the pancreatitis is not caused by the
experimental setting (except the intraductal injection of
bile acid), surgical trauma or anesthesia or TEA. No
differences regarding pancreatic microcirculation and
tissue oxygenation were detected and no sign of pan-
creatitis or inflammation was found in the histopatho-
logic examination.
An issue worth discussing is the interval between
induction of pancreatitis and the beginning of treatment.
In our study, the interval chosen was rather short.
However, to our understanding this seems to be adequate,
because the direct intraductal injection of bile acid
induces an acute pancreatitis within a few minutes, which
is much faster than acute biliary pancreatitis found in the
clinical setting [50,51]. In our experimental setting,
SAP was observed macroscopically in all animals
prior to the beginning of therapeutic intervention. If
the interval between induction and beginning of the
Table 4 Laboratory results of analysis of hemoglobin, leucocyte count, thrombocyte count, prothrombin time (PT), partial thromboplastin time (PTT),
creatinine, aspartate-transaminase (AST), alanine-transferase (ALT), pancreatic amylase and total bilirubin
Group M 0 M 1 M 2 M 3 M 4 M 5 M 6 M 7 M 8 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Hemoglobin
(g/dl)
TEA 8.8 ± 0.6 8.6 ± 0.6 8.2 ± 0.6 8.7 ± 0.7 9.1 ± 0.9 8.6 ± 0.5 8.6 ± 0.5 8.4 ± 0.7 8.2 ± 0.8 9.7 ± 0.8 9.6 ± 1.4 9.3 ± 1.2 9.2 ± 1.4 9.4 ± 1.2 9.3 ± 1.2 8.6 ± 1.4
Controll 8.6 ± 0.5 8.7 ± 0.5 8.1 ± 0.6 8.5 ± 0.4 8.7 ± 0.5 8.4 ± 0.7 8.5 ± 0.9 8.0 ± 0.9 7.8 ± 0.6 9.5 ± 0.5 9.4 ± 1.2 9.4 ± 0.9 9.3 ± 0.4 9.3 ± 1.6 10.0 ± 0.7 9.5 ± 1.0
Leucocytes
(109/L)
TEA 9.2 ± 3.0 8.7 ± 3.9 10.8 ± 4.0 9.4 ± 4.5 11.9 ± 4.4 11.8 ± 3.4 11.0 ± 3.0 10.5 ± 3.4 9.5 ± 4.3 11.0 ± 4.0 15.1 ± 4.6 18.8 ± 6.8 17.0 ± 7.1 23.4 ± 7.4 24.1 ± 7.6 23.5 ± 7.2
Controll 9.0 ± 3.4 11.3 ± 3.2 12.8 ± 5.3 11.9 ± 2.4 13.3 ± 3.1 12.8 ± 3.3 12.4 ± 3.8 11.6 ± 3.4 9.8 ± 4.3 11.4 ± 3.5 17.9 ± 4.6 18.2 ± 6.6 17.7 ± 3.9 21.5 ± 6.7 25.0 ± 2.4 21.2 ± 6.3
Thrombocytes
(109/L)
TEA 279 ± 97 196 ± 40 263 ± 72 176 ± 13 202 ± 38 191 ± 15 198 ± 19 186 ± 29 266 ± 97 356 ± 148 337 ± 103 380 ± 140 417 ± 174 445 ± 191 408 ± 178 403 ± 151
Control 322 ± 97 240 ± 41 296 ± 100 251 ± 32 237 ± 42 250 ± 40 233 ± 20 211 ± 18 272 ± 100 366 ± 99 321 ± 94 333 ± 63 361 ± 100 423 ± 164 353 ± 175 408 ± 101
PT (seconds) TEA 108 ± 9 110 ± 5 107 ± 8 112 ± 7 110 ± 6 113 ± 4 110 ± 7 110 ± 9 107 ± 10 94 ± 10 112 ± 8 109 ± 15 102 ± 12 98 ± 13 98 ± 11 94 ± 11
Control 115 ± 8 108 ± 5 105 ± 23 107 ± 3 106 ± 5 104 ± 9 105 ± 5 101 ± 8 101 ± 11 97 ± 9 100 ± 31 112 ± 13 114 ± 14 104 ± 15 109 ± 11 98 ± 11
PTT (seconds) TEA 89 ± 16 79 ± 15 85 ± 24 81 ± 27 86 ± 10 91 ± 26 93 ± 15 76 ± 4 92 ± 30 134 ± 22 103 ± 40 109 ± 22 79 ± 42 97 ± 48 107 ± 48 43 ± 25
Control 84 ± 21 81 ± 18 86 ± 27 84 ± 27 82 ± 19 90 ± 30 75 ± 19 88 ± 19 98 ± 19 121 ± 25 111 ± 30 100 ± 33 87 ± 41 69 ± 17 79 ± 27 58 ± 14
Creatinine
(mg/dl)
TEA 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.2 0.8 ± 0.1 0.8 ± 0.2 0.7 ± 0.2 0.8 ± 0.2 0.9 ± 0.4 1.0 ± 1.0 1.1 ± 1.3 1.2 ± 2.0
Control 0.7 ± 0.1 0.8 ± 0.1 0.7 ± 0.1 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.3 0.8 ± 0.1 0.7 ± 0.1 0.7 ± 0.2 0.6 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 0.7 ± 0.2 0.7 ± 0.1
AST (U/L) TEA 38 ± 13 42 ± 22 38 ± 14 45 ± 18 48 ± 20 47 ± 19 51 ± 22 52 ± 18 60 ± 21 348 ± 220 116 ± 62 54 ± 25 40 ± 19 32 ± 15 30 ± 14 41 ± 48
Control 34 ± 11 40 ± 12 40 ± 15 40 ± 13 43 ± 10 46 ± 13 51 ± 8 51 ± 13 58 ± 19 319 ± 116 86 ± 27 45 ± 12 33 ± 5 30 ± 4 29 ± 12 32 ± 9
ALT (U/L) TEA 77 ± 15 80 ± 6 63 ± 13 77 ± 9 76 ± 5 70 ± 9 66 ± 4 63 ± 8 50 ± 8 111 ± 30 105 ± 25 93 ± 24 77 ± 24 74 ± 19 66 ± 16 49 ± 15
Control 76 ± 13 70 ± 12 63 ± 11 62 ± 9 61 ± 11 55 ± 8 55 ± 9 47 ± 7 46 ± 10 115 ± 28 105 ± 21 88 ± 15 82 ± 9 81 ± 13 71 ± 13 50 ± 12
Amylase (U/L) TEA 2155 ± 368 2606 ± 103 2388 ± 509 2808 ± 137 2960 ± 280 2895 ± 250 3011 ± 187 3045 ± 319 3153 ± 965 8726 ± 3736 8196 ± 4195 6745 ± 4591 4316 ± 2923 3966 ± 2930 3909 ± 3319 3225 ± 3886
Control 1971 ± 432 2165 ± 476 2249 ± 814 2278 ± 556 2479 ± 541 2567 ± 699 2876 ± 953 2733 ± 978 3261 ± 1296 10186 ± 5195 9001 ± 6610 8472 ± 5937 8109 ± 7347 6726 ± 5501 10129 ± 6670 7926 ± 6196
Bilirubin
(mg/dl)
TEA 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.4 ± 0.2 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1
Control 0.2 ± 0.1 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.1 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
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pancreatic microcirculation may not occur when fulmin-
ate necroses are already present, as the rationale for the
treatment approach is to improve microcirculatory perfu-
sion and thereby save not yet irreversibly injured tissue
from infarction and necrosis [52,53]. This should not be
forgotten and similar to approaches for early goal-directed
hemodynamic stabilization by fluid therapy in systemic in-
flammation, it probably holds true that the treatment
interval needs to be short and TEA should be commenced
as early as possible.
Concerning the animal model, pigs were chosen
since in smaller animals no adequate hemodynamic
monitoring and therapy is possible. This is essential
to rule out macrocirculatory effects on pancreatic
microcirculation as potential confounding factors in-
fluencing the estimation of the effects of TEA in our
trial. The combination of invasive intrapancreatic
measurement of tissue oxygenation and microcircula-
tion by microvascular blood flow not only allows a
reliable assessment of the pancreatic microcirculatory
conditions, it also allows evaluation of the amount of
oxygen reaching the end organ. Although a subs-
tantial benefit of TEA in SAP was detected in our
animal model, the direct transfer of the results to
humans is not proven. The conception of the trial with a
seven-day observation period allowed evaluation of the
outcome for SAP and in this regard represents a good
model closely mimicking the clinical situation and an im-
portant basis for potential further prospective randomized
clinical trials.
Another fact is that measurement of pancreatic tis-
sue oxygenation and microcirculation was limited to a
period of only six hours. For this reason, we cannot
make a definite statement on the effects of TEA on
pancreatic microcirculation and tissue oxygenation in
the later course. Nonetheless, the effects and differ-
ences are present at an early stage and TEA led to a
significant improvement in survival and less histo-
pathologic damage. This strengthens the assumption
of our hypothesis that TEA has a relevant therapeutic
effect in SAP.
Conclusions
In conclusion, our data suggest that application of TEA
resulted in improved survival and led to enhanced pan-
creatic microcirculation and tissue oxygenation resulting
in reduced histopathologic damage in a model of severe
acute porcine pancreatitis.
Key messages
 The use of epidural anesthesia in systemic
inflammation is still controversial. The results of our study suggest that there is a
relevant improvement in pancreatic microcirculation
and tissue oxygenation due to the use of TEA
in SAP.
 We could demonstrate that this improvement
due to TEA resulted in less histopathologic damage
and improved survival.
 Further evaluation is required to transfer these
promising results into clinical practice.
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